A.R.T. Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-13,706
| Closed | -$711K | – | 99 |
|
|
2019
Q4 | $711K | Buy |
13,706
+7,200
| +111% | +$374K | 0.04% | 687 |
|
|
2019
Q3 | $357K | Sell |
6,506
-8,400
| -56% | -$461K | 0.02% | 991 |
|
|
2019
Q2 | $605K | Buy |
+14,906
| New | +$605K | 0.03% | 670 |
|
|
2018
Q4 | – | Sell |
-28,212
| Closed | -$1.19M | – | 1296 |
|
|
2018
Q3 | $1.19M | Buy |
28,212
+17,750
| +170% | +$748K | 0.05% | 500 |
|
|
2018
Q2 | $334K | Sell |
10,462
-6,441
| -38% | -$206K | 0.01% | 1072 |
|
|
2018
Q1 | $840K | Buy |
16,903
+6,600
| +64% | +$328K | 0.03% | 728 |
|
|
2017
Q4 | $555K | Buy |
10,303
+4,600
| +81% | +$248K | 0.02% | 853 |
|
|
2017
Q3 | $330K | Buy |
+5,703
| New | +$330K | 0.02% | 974 |
|
|
2017
Q2 | – | Sell |
-12,900
| Closed | -$560K | – | 1381 |
|
|
2017
Q1 | $560K | Buy |
12,900
+3,500
| +37% | +$152K | 0.03% | 774 |
|
|
2016
Q4 | $460K | Buy |
+9,400
| New | +$460K | 0.03% | 783 |
|
|
2016
Q2 | – | Sell |
-22,858
| Closed | -$1.02M | – | 1342 |
|
|
2016
Q1 | $1.02M | Buy |
22,858
+1,100
| +5% | +$49.2K | 0.05% | 578 |
|
|
2015
Q4 | $830K | Buy |
21,758
+13,400
| +160% | +$511K | 0.04% | 655 |
|
|
2015
Q3 | $266K | Sell |
8,358
-9,907
| -54% | -$315K | 0.01% | 1078 |
|
|
2015
Q2 | $603K | Buy |
18,265
+12,752
| +231% | +$421K | 0.02% | 924 |
|
|
2015
Q1 | $226K | Sell |
5,513
-34,493
| -86% | -$1.41M | 0.01% | 1196 |
|
|
2014
Q4 | $1.63M | Buy |
40,006
+4,502
| +13% | +$183K | 0.06% | 451 |
|
|
2014
Q3 | $1.3M | Buy |
35,504
+12,646
| +55% | +$463K | 0.06% | 430 |
|
|
2014
Q2 | $1.06M | Buy |
22,858
+12,257
| +116% | +$568K | 0.06% | 484 |
|
|
2014
Q1 | $435K | Buy |
+10,601
| New | +$435K | 0.02% | 814 |
|